Inhibikase Therapeutics (IKT) Enterprise Value (2020 - 2026)
Inhibikase Therapeutics' Enterprise Value came in at $195.36 million for Q2 2026, up 238.9% from $57.64 million a year earlier and up 64.0% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Enterprise Value (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Inhibikase Therapeutics reported Enterprise Value of -$231.09 million; for FY2025, it came in at $22.77 million.
- Enterprise Value carries a five-year compound annual growth rate of -11.8% (FY2020 to FY2025).
- Going back by year, Enterprise Value was -$20.48 million in FY2024, -$5.4 million in FY2023, -$10.44 million in FY2022 and -$13.98 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Enterprise Value in data going back to Q4 2020.
- Business Quant data shows IKT's Enterprise Value at $119.11 million (Q1 2026), $22.77 million (Q4 2025) and $43.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.85 Bn | 1,106.43 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 618.85 Bn | 537.37 Bn | 17.26 Bn |
| 3 | AbbVie | 503.03 Bn | 476.14 Bn | 12.70 Bn |
| 4 | Merck | 368.52 Bn | 322.90 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.19 Bn | 262.18 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn |
| 7 | Amgen | 237.14 Bn | 192.53 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.35 Bn | 165.54 Bn | 6.22 Bn |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn |
| 10 | Inhibikase Therapeutics | 288.92 Mn | -296.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 195.36 Mn |
| Mar 31, 2026 | 119.11 Mn |
| Dec 31, 2025 | 22.77 Mn |
| Sep 30, 2025 | 43.87 Mn |
| Jun 30, 2025 | 57.64 Mn |
| Mar 31, 2025 | 69.63 Mn |
| Dec 31, 2024 | -20.48 Mn |
| Sep 30, 2024 | 6.46 Mn |
| Jun 30, 2024 | 791,521.73 |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | -5.40 Mn |
| Sep 30, 2023 | -9.38 Mn |
| Jun 30, 2023 | -1.84 Mn |
| Mar 31, 2023 | -5.27 Mn |
| Dec 31, 2022 | -10.44 Mn |
| Sep 30, 2022 | -3.58 Mn |
| Jun 30, 2022 | -13.46 Mn |
| Mar 31, 2022 | 725,619.32 |
| Dec 31, 2021 | -13.98 Mn |
| Sep 30, 2021 | 2.95 Mn |
API Access
Inhibikase Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();